Welcome to the Roberts, Carroll, Feldstein and Peirce Quarterly Newsletter.

Questions, comments, suggestions and/or feedback concerning any of the items covered in this newsletter, or any other matter, are always welcome. If you have an idea, issue or topic you would like us to address, please email us at rcfpevents@rcfp.com.

Please click below to read additional articles from this issue of our Quarterly Newsletter.

Quarterly Newsletter: December 2013

Department of Health Regulations: Medical Orders For Life Sustaining Treatment

Although it cannot, and should not, be considered to be a substitute for advance directives, including living wills and health care powers of attorney, a MOLST (Medical Order for Life Sustaining Treatment) provides a mechanism for translating end of life wishes into medical orders. Regulations recently reviewed by the Department of Health, and the release of a MOLST form, should help ensure a patient’s end-of-life wishes are fulfilled.

Welcome to the Roberts, Carroll, Feldstein and Peirce Quarterly Newsletter.

Questions, comments, suggestions and/or feedback concerning any of the items covered in this newsletter, or any other matter, are always welcome. If you have an idea, issue or topic you would like us to address, please email us at rcfpevents@rcfp.com.

Please click below to read additional articles from this issue of our Quarterly Newsletter.

Quarterly Newsletter: December 2013

Department of Health Regulations: Medical Orders For Life Sustaining Treatment

Although it cannot, and should not, be considered to be a substitute for advance directives, including living wills and health care powers of attorney, a MOLST (Medical Order for Life Sustaining Treatment) provides a mechanism for translating end of life wishes into medical orders. Regulations recently reviewed by the Department of Health, and the release of a MOLST form, should help ensure a patient’s end-of-life wishes are fulfilled.